|
1
|
Cao M and Chen W: Epidemiology of lung
cancer in China. Thorac Cancer. 10:3–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li C, Lei S, Ding L, Xu Y, Wu X, Wang H,
Zhang Z, Gao T, Zhang Y and Li L: Global burden and trends of lung
cancer incidence and mortality. Chin Med J (Engl). 136:1583–1590.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li D, Shi J, Liang D, Ren M and He Y: Lung
cancer risk and exposure to air pollution: A multicenter North
China case-control study involving 14604 subjects. BMC Pulm Med.
23:1822023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang Y, Li Z, Chen H, Zhang T, Yin X, Man
J, Yang X and Lu M: Burden of lung cancer along with attributable
risk factors in China from 1990 to 2019, and projections until
2030. J Cancer Res Clin Oncol. 149:3209–3218. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Imyanitov EN, Iyevleva AG and Levchenko
EV: Molecular testing and targeted therapy for non-small cell lung
cancer: Current status and perspectives. Crit Rev Oncol Hematol.
157:1031942021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiang Y, Liu X, Wang Y, Zheng D, Meng Q,
Jiang L, Yang S, Zhang S, Zhang X, Liu Y and Wang B: Mechanisms of
resistance to targeted therapy and immunotherapy in non-small cell
lung cancer: Promising strategies to overcoming challenges. Front
Immunol. 15:13662602024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lei G and Zhuang Gan B: Targeting
ferroptosis as a vulnerability in cancer. Nat Rev Cancer.
22:381–396. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fang K, Du S, Shen D, Xiong Z, Jiang K,
Liang D, Wang J, Xu H, Hu L, Zhai X, et al: SUFU suppresses
ferroptosis sensitivity in breast cancer cells via Hippo/YAP
pathway. iScience. 25:1046182022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niu X, Han P, Liu J, Chen Z and Ma X,
Zhang T, Li B and Ma X: Regulation of Hippo/YAP signaling pathway
ameliorates cochlear hair cell injury by regulating ferroptosis.
Tissue Cell. 82:1020512023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui J, Wang Y, Tian X, Miao Y, Ma L, Zhang
C, Xu X, Wang J, Fang W and Zhang X: LPCAT3 is transcriptionally
regulated by YAP/ZEB/EP300 and collaborates with ACSL4 and YAP to
determine ferroptosis sensitivity. Antioxid Redox Signal.
39:491–511. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Ye Z, Xia Y, Li B, Chen L, Yan X,
Yuan T, Song B, Yu W, Rao T, et al: YAP/ACSL4 pathway-mediated
ferroptosis promotes renal fibrosis in the presence of kidney
stones. Biomedicines. 11:26922023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu Z, Sun J, Liao Z, Sun T, Huang L, Qiao
J, Ling C, Chen C, Zhang B and Wang H: Activation of PAR1
contributes to ferroptosis of Schwann cells and inhibits
regeneration of myelin sheath after sciatic nerve crush injury in
rats via Hippo-YAP/ACSL4 pathway. Exp Neurol. 384:1150532025.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu Y, Wu S, Fan J, Meng Z, Gao G, Liu T,
Wang Q, Xia H, Wang X and Wu K: CYLD regulates cell ferroptosis
through Hippo/YAP signaling in prostate cancer progression. Cell
Death Dis. 15:792024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao Z, Xiao W and Li G: Research progress
on the pharmacological action of Schisantherin A. Evid Based
Complement Alternat Med. 2022:64208652022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mi X, Zhang Z, Cheng J, Xu Z, Zhu K and
Ren Y: Cardioprotective effects of Schisantherin A against
isoproterenol-induced acute myocardial infarction through
amelioration of oxidative stress and inflammation via modulation of
PI3K-AKT/Nrf2/ARE and TLR4/MAPK/NF-κB pathways in rats. BMC
Complement Med Ther. 23:2772023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen Y, Yang Y, Zhao Y, Nuerlan S, Zhan Y
and Liu C: YY1/circCTNNB1/miR-186-5p/YY1 positive loop aggravates
lung cancer progression through the Wnt pathway. Epigenetics.
19:23690062024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie C, Zhou X, Wu J, Chen W, Ren D, Zhong
C, Meng Z, Shi Y and Zhu J: ZNF652 exerts a tumor suppressor role
in lung cancer by transcriptionally downregulating cyclin D3. Cell
Death Dis. 15:7922024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lussier G, Evans AJ, Houston I, Wilsnack
A, Russo CM, Vietor R and Bedocs P: Compact arterial monitoring
device use in resuscitative endovascular balloon occlusion of the
aorta (REBOA): A simple validation study in swine. Cureus.
16:e707892024.PubMed/NCBI
|
|
20
|
Jonna S and Subramaniam DS: Molecular
diagnostics and targeted therapies in non-small cell lung cancer
(NSCLC): An update. Discov Med. 27:167–170. 2019.PubMed/NCBI
|
|
21
|
Wang M, Herbst RS and Boshoff C: Toward
personalized treatment approaches for non-small-cell lung cancer.
Nat Med. 27:1345–1356. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng F, Pan L, Wu J, Liu M, He L, Yang L
and Zhou W: Schisantherin A inhibits cell proliferation by
regulating glucose metabolism pathway in hepatocellular carcinoma.
Front Pharmacol. 13:10194862022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Yu K, Hu Y, Su F, Gao Z, Hu T,
Yang Y, Cao X and Qian F: Schisantherin A induces cell apoptosis
through ROS/JNK signaling pathway in human gastric cancer cells.
Biochem Pharmacol. 173:1136732020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xian H, Feng W and Zhang J: Schizandrin A
enhances the efficacy of gefitinib by suppressing IKKβ/NF-κB
signaling in non-small cell lung cancer. Eur J Pharmacol.
855:10–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu L, Wang Y, Huang X, Liu X, Ye B, He Y,
Yu H, Lv W, Wang L and Hu J: Schizandrin A induces non-small cell
lung cancer apoptosis by suppressing the epidermal growth factor
receptor activation. Cancer Med. 13:e69422024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nilsson MB, Yang Y, Heeke S, Patel SA,
Poteete A, Udagawa H, Elamin YY, Moran CA, Kashima Y, Arumugam T,
et al: CD70 is a therapeutic target upregulated in EMT-associated
EGFR tyrosine kinase inhibitor resistance. Cancer Cell. 41:340–355.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shyam Sunder S, Sharma UC and Pokharel S:
Adverse effects of tyrosine kinase inhibitors in cancer therapy:
Pathophysiology, mechanisms and clinical management. Signal
Transduct Target Ther. 8:2622023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qian LH, Wen KL, Guo Y, Liao YN, Li MY, Li
ZQ, Li SX and Nie HZ: Nutrient deficiency-induced downregulation of
SNX1 inhibits ferroptosis through PPARs-ACSL1/4 axis in colorectal
cancer. Apoptosis. 30:1391–1409. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu X, Sheng H, Zhao L, Jiang M, Lou H,
Miao Y, Cheng N, Zhang W, Ding D and Li W: Co-loaded lapatinib/PAB
by ferritin nanoparticles eliminated ECM-detached cluster cells via
modulating EGFR in triple-negative breast cancer. Cell Death Dis.
13:5572022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo W: Nasopharyngeal carcinoma ecology
theory: Cancer as multidimensional spatiotemporal ‘unity of ecology
and evolution’ pathological ecosystem. Theranostics. 13:1607–1631.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsu PC, Yang CT, Jablons DM and You L: The
crosstalk between Src and Hippo/YAP signaling pathways in non-small
cell lung cancer (NSCLC). Cancers (Basel). 12:13612020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu M, Wu H and Xu C: Targeting cancer
stem cell pathways for lung cancer therapy. Curr Opin Oncol.
35:78–85. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zakaria N, Satar NA, Abu Halim NH, Ngalim
SH, Yusoff NM, Lin J and Yahaya BH: Targeting lung cancer stem
cells: Research and clinical impacts. Front Oncol. 7:802017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng Y, Yang W, Wu W, Jin F, Lu D, Gao J
and Wang S: Diagnostic and predictive significance of the
ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells
based on multi-omics. Transl Oncol. 45:1019262024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou J, Zhang L, Yan J, Hou A, Sui W and
Sun M: Curcumin induces ferroptosis in A549 CD133+ cells
through the GSH-GPX4 and FSP1-CoQ10-NAPH Pathways. Discov Med.
35:251–263. 2023. View Article : Google Scholar : PubMed/NCBI
|
